- Filed
- Nov 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 7, 2024 | 29.27M sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $1.64K |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $638 |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $2.18M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $1.82M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $2.18M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $1.82M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $1.64K |
| Current Assets | Q3 2024 · Dec 31, 2023 | $638 |
| Total Assets | Q3 2024 · Sep 30, 2024 | $1.64K |
| Total Assets | Q3 2024 · Dec 31, 2023 | $638 |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 29.27M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 29.27M sh |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$39.62K |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | −$1.7M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | −$1.59M |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | −$1.48M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | −$1.35M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.00 |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$0.01 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.00 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$0.01 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $7.86K |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $40.29K |
| Net Income | Q3 2024 · Sep 30, 2023 | −$113.61K |
| Net Income | Q3 2024 · Sep 30, 2023 | −$357.54K |